Anika Therapeutics, Inc.
2.08xPrice / tangible book
Market cap
$278.50M
Tangible equity
$133.76M
Price / tangible book
2.08x
Price / book
1.94x
Return on equity
-7.6%
Return on assets
-5.7%
Efficiency ratio
—
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: ANIK stock price near parity vs MTB $20.81 current versus $16.77 implied using P/TBV multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at MTB's multiple
Implied fair value · at ANIK's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Filter, sort, and scan the equity metrics that matter most for banks: book value, tangible book, returns, and operating efficiency.
Multiple premium
Multiple premium
Profitability lag
Asset efficiency lag
Lower is better
Statements
Bank-focused income statement and equity metrics aligned to the reporting windows.
SEC periods: ANIK FY 2025 (ended Dec 31, 2025) · MTB FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Tangible book and profitability anchor a bank, not enterprise value.
Deposits and cash-like balances distort enterprise value for banks, so this section reads equity value, tangible book and profitability instead.
Price / tangible book
Market cap
$278.50M
Tangible equity
$133.76M
Price / tangible book
2.08x
Price / book
1.94x
Return on equity
-7.6%
Return on assets
-5.7%
Efficiency ratio
—
Price / tangible book
Market cap
$34.64B
Tangible equity
$20.65B
Price / tangible book
1.68x
Price / book
1.19x
Return on equity
9.8%
Return on assets
1.3%
Efficiency ratio
41.5%
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Anika Therapeutics, Inc. · implied price per share
At least 3 of the last 5 annual free-cash-flow observations must be positive.
M&T BANK CORPORATION · implied price per share
Bank model off — standard DCF modelling is disabled for financial institutions.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
-0.00x
0.45x
Net debt / EBITDA
Leverage against operating earnings
34.65x
—
Cash and equivalents
Liquid reserves on the balance sheet
$81.17M
—
Total debt
Interest-bearing obligations outstanding
-$149.00K
$13.06B
Comparable set
Where the pair sits against the wider banking comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
ZIMMER BIOMET HOLDINGS, INC.
ANIK vs ZBH
STRYKER CORP
ANIK vs SYK
BECTON DICKINSON & CO
ANIK vs BDX
INTEGRA LIFESCIENCES HOLDINGS CORP
ANIK vs IART
JPMorgan Chase & Co.
ANIK vs JPM
Bank of America Corporation
ANIK vs BAC
Wells Fargo & Company
ANIK vs WFC
Citigroup Inc.
ANIK vs C
PNC FINANCIAL SERVICES GROUP, INC.
ANIK vs PNC
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.